IN C014
Alternative Names: IN-C014Latest Information Update: 25 Oct 2021
At a glance
- Originator HK inno.N
- Class Antihyperglycaemics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 25 Oct 2021 Discontinued for Diabetes mellitus in South Korea (unspecified route) before October 2021 (HK inno.N pipeline, October 2021)
- 20 Apr 2021 Early research in Diabetes mellitus in South Korea (unspecified route), prior to April 2021 (HK inno.N pipeline, April 2021)